Quick Answer
Bluejay Diagnostics, Inc. reported Operating Income of -$6.95 million for fiscal year 2025.
Bluejay Diagnostics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$6.95M | +3.0% |
| 2024 | -$7.17M | +30.5% |
| 2023 | -$10.31M | -10.7% |
| 2022 | -$9.32M | -188.5% |
| 2021 | -$3.23M | -170.0% |
| 2020 | -$1.20M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.62M | -18.8% | +18.6% |
| June 30, 2025 | -$1.99M | -4.8% | -5.1% |
| March 31, 2025 | -$1.89M | +22.2% | -38.7% |
| September 30, 2024 | -$1.36M | +41.8% | +28.2% |
| June 30, 2024 | -$1.90M | +34.7% | +21.9% |
| March 31, 2024 | -$2.43M | +9.4% | -3.7% |
| September 30, 2023 | -$2.34M | +16.7% | +19.4% |
| June 30, 2023 | -$2.90M | -46.2% | -8.4% |
- Bluejay Diagnostics, Inc. showed an increase of +3.0% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Bluejay Diagnostics, Inc.’s operating income has declined by 481.2% (from -$1.20 million to -$6.95 million).
- The most recent figure is from Bluejay Diagnostics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: